Dr Alice Yeonkyung Iya, MD | |
12222 Merit Dr Ste 600, Dallas, TX 75251-3294 | |
(888) 339-8727 | |
Not Available |
Full Name | Dr Alice Yeonkyung Iya |
---|---|
Gender | Female |
Speciality | Anesthesiology |
Location | 12222 Merit Dr Ste 600, Dallas, Texas |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104352095 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | T5584 (Texas) | Primary |
Entity Name | U S Anesthesia Partners Of Texas, Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1548208564 PECOS PAC ID: 7315850351 Enrollment ID: O20031106000563 |
News Archive
US Oncology, Inc., the nation's premier oncology services company supporting the nation's largest network including more than 1,300 oncologists and more than 10,000 clinicians and cancer experts to advance cancer care in America, was honored on Feb. 6, by Texas Governor Rick Perry at the Texas vs. the Nation All-Star Football Challenge in El Paso, Texas. US Oncology was honored as an inaugural inductee to the Governor's Business Hall of Fame along with Baker Hughes, Bell Helicopter, and Texas Instruments.
A team of researchers from Imperial College London has conducted a study aimed at calculating a reasonably accurate case fatality ratio and infection fatality ratio, which is based on Chinese data as well as international reports. The research is published on the pre-print server MedRxiv.
With the Gold Coast Commonwealth Games looming in 2018, a key concern for athletes will be how to prevent illness from interfering with their training and performance.
Centocor Ortho Biotech Products, L.P., today announced that it has voluntarily withdrawn the New Drug Application for trabectedin for the treatment of women with recurrent ovarian cancer. The withdrawal is based on the U.S. Food and Drug Administration's recommendation that an additional Phase 3 study be conducted to obtain approval.
Amblyopia, commonly known as "lazy-eye," has been classically treated by patching the strong eye to force the weaker eye to be used. However, the concept of binocular dysfunction, in which the brain suppresses the image from the weaker eye in favor of the stronger eye, has motivated new approaches to amblyopia treatment.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Alice Yeonkyung Iya, MD Po Box 840853, Dallas, TX 75284-0853 Ph: (972) 233-1999 | Dr Alice Yeonkyung Iya, MD 12222 Merit Dr Ste 600, Dallas, TX 75251-3294 Ph: (888) 339-8727 |
News Archive
US Oncology, Inc., the nation's premier oncology services company supporting the nation's largest network including more than 1,300 oncologists and more than 10,000 clinicians and cancer experts to advance cancer care in America, was honored on Feb. 6, by Texas Governor Rick Perry at the Texas vs. the Nation All-Star Football Challenge in El Paso, Texas. US Oncology was honored as an inaugural inductee to the Governor's Business Hall of Fame along with Baker Hughes, Bell Helicopter, and Texas Instruments.
A team of researchers from Imperial College London has conducted a study aimed at calculating a reasonably accurate case fatality ratio and infection fatality ratio, which is based on Chinese data as well as international reports. The research is published on the pre-print server MedRxiv.
With the Gold Coast Commonwealth Games looming in 2018, a key concern for athletes will be how to prevent illness from interfering with their training and performance.
Centocor Ortho Biotech Products, L.P., today announced that it has voluntarily withdrawn the New Drug Application for trabectedin for the treatment of women with recurrent ovarian cancer. The withdrawal is based on the U.S. Food and Drug Administration's recommendation that an additional Phase 3 study be conducted to obtain approval.
Amblyopia, commonly known as "lazy-eye," has been classically treated by patching the strong eye to force the weaker eye to be used. However, the concept of binocular dysfunction, in which the brain suppresses the image from the weaker eye in favor of the stronger eye, has motivated new approaches to amblyopia treatment.
› Verified 1 days ago
Lee M. Lunsford, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-8000 | |
Dr. Stephanie C Jones, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-9374 | |
Dr. Alfredo Ruben Lopez, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 6606 Lbj Fwy Ste 200, Dallas, TX 75240 Phone: 972-715-5000 Fax: 972-715-9976 | |
Dr. Elvis Tsang, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 12222 Merit Dr Ste 600, Dallas, TX 75251 Phone: 972-715-5000 Fax: 972-715-9976 | |
Dr. Christopher D Lecheminant, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 6606 Lbj Fwy Ste 200, Dallas, TX 75240 Phone: 972-715-5000 | |
Dr. Mihir N Rane, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3625 N Hall St Ste 800, Dallas, TX 75219 Phone: 214-252-3500 | |
Lisa Gu, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-6400 |